RA Capital Nexus Fund II, Director: Climb Bio CLYM Buy · Filed 01/07

Trade details

Type: Insider buy
Amount: $24,888.5
Shares · price: 7,111 sh · $3.50 a share
Held after: 3,403,429 sh
Stock: Climb Bio CLYM
Person: RA Capital Nexus Fund IIDirector
Trade date: 26/01/05
Filed: 26/01/07
Days to filing: 2 days

First buy since 2023

Insiders buying this week: 7 insiders
Holding change: +0.2%

Climb Bio trades, last 26 weeks

What else happened in Climb Bio around then

Filed or reported within 30 days of the trade day · 25/12/06~02/04

RA Capital Nexus Fund II's recent trades

RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$45.7M
2,541,250 sh
$45.7M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.4M
133,750 sh
$2.4M
Filed 05/06
Traded 05/04
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$2.1M
87,143 sh
$2.1M
Filed 05/06
Traded 05/05
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$1.3M
53,407 sh
$1.3M
Filed 05/06
Traded 05/06
RA Capital Nexus Fund IIDirector
BuyHemab Therapeutics Holdings
Buy
Hemab Therapeutics Holdings
COAG
$347.3K
14,611 sh
$347.3K
Filed 05/06
Traded 05/06

RA Capital Nexus Fund II, Director — bought $24.9K of Climb Bio CLYM · 7,111 sh @ $3.50 | Whalegun